To examine the effect of PRMT3 KO on the response of HCC cells to OXA in vivo, we subjected tumor-bearing mice implanted with PRMT3-KO and -WT PLC-8024 cells to vehicle or OXA treatment (Supplementary Fig. 3a). Here, PRMT3 is linked to hepatocellular carcinoma.